Thus, we aimed to assess the number of CD34+/CD144+ and CD34+/KDR+ cells in the peripheral blood of patients undergoing coronary artery bypass grafting (CABG) with angiographic demonstration of CAD, compared to valvular surgery patients with angiographic demonstration of absence of CAD. The gene discussed is KDR; the disease is coronary artery disorder.